Concepedia

James Brett Case

JB

Statistics

Publications

89

Citations

19.7K

H-Index

52

Active since

2008

Affiliations

Washington University in St. Louis(Current)

Vanderbilt University Medical Center

Harvard University

VIR Biotechnology (United States)

The University of Texas Medical Branch at Galveston

James Brett Case is an author at Washington University in St. Louis specializing in infectious diseases, immunology, and sars-cov-2 infection.

ORCID

Publications per year

2008–2024

89

Publications

89

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto, Young‐Jun Park, Martina Beltramello et al. · Nature · 2020 · 2.2K citations · Full text

, , +10

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

, , +14

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini, Erica L. Andres, Amy Sims et al. · mBio · 2018 · 1.5K citations · Full text

, , +16

Potently neutralizing and protective human antibodies against SARS-CoV-2

Seth J. Zost, Pavlo Gilchuk, James Brett Case et al. · Nature · 2020 · 1.2K citations · Full text

, , +14

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen, Xianwen Zhang, James Brett Case et al. · Nature Medicine · 2021 · 1K citations · Full text

, , +17

1–5 of 89